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The aims of this study were to explore pharmacists' perception towards the 
contributing factors for the existence of unregistered drugs in the market, 
the reasons for the public to select the unregistered drugs, to determine the 
association between the awareness of general retailers and the offences as 
well as to develop and validate a knowledge tool towards registered drugs 
and to identify the association with the knowledge of the public and socio-
demographics. This study used the action research concept. Three types 
of participants were involved; pharmacist, public and general retailers and 
the setting around Klang Valley area. Two different semi-guided and face-
to-face interviewed and purposive selection criteria were used to explore 
the pharmacist (n=16) and public (n=21) perception. The retrospective 
data (n=1441) from inspection report in Selangor was used to determine 
the association of awareness and offences amongst general retailers. The 
instrument constructed by analysing the specific literature in the area of 
registered drugs information in Malaysia. Then the involvement of expert 
panel (n=10) expertise to validate the content and public (n=10) for the 
reproducibility. Then, followed by the pilot test (n=T00), and continued with 
a final survey (n=466) by using a convenient sample. The reproducibility 
obtained via the intraclass correlation coefficient by using the test-retest 
method. Internal consistency assessed using Cronbach's alpha and construct 
validity used exploratory factor analysis. The thematic content analysis for 
both of the perceptions identified pharmacists' perception (25 themes) and 
publics' perception (7 themes). The majority of the pharmacists believed 
that low health literacy is one of the primary reasons of the contributing 
factors for the existence of unregistered drugs. Moreover, the majority of 
the public believed that the reason they select the unregistered drugs is 
because of the familiarity of the products and appearance of the packaging. 
Instead, a majority of the public who did not select the unregistered drugs 
believed the absence of certain characteristics of the packaging and the 
authorised sticker. In total, only 32.9% of general retailers were aware of 
registered drugs and 67.1% general retailers were not aware of registered 
drugs. The result showed there was an insignificant association (p=0.226) 
between awareness and offences. The final version of the questionnaire 
had 12 questions which divided into five areas of information that needed 
for educating the consumer on registered drugs. This questionnaire had 
a clarity index of 8.78 ± 0.51. The intraclass correlation coefficient was 
0.96, and Cronbach's alpha, 0.866. Factor analysis revealed five factors 
associated with the knowledge areas. The final survey conducted and the 
final scores compared with the socio-demographic participants showed that 
age, race, the level of education and occupation significantly associated 
with levels of knowledge except for gender (p=0.485). This study has 
found that by exploring and investigating pharmacist, public and general 
retailers regarding these issues give a convergent answer that the main 
contributor of the unregistered drugs is the low level of knowledge and 
awareness towards registered and unregistered drugs. Thus enhancement of 
consumers' knowledge is one of the leading solutions that government can 
improve in the future. 
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Despite complex pharmacotherapy management in neonates, the 
epidemiology of drug utilization, drug related problems (DRPs) and their 
predictors in hospitalized neonates in Malaysia are unknown. Thus, the aims 
of this study were to examine the drug utilization profile, DRPs and their 
predictors in hospitalized neonates. A systematic review was conducted prior 
to the actual study to determine the prescribing patterns and methodologies 
used for reporting drug utilization in hospitalized neonates. Two projects were 
undertaken under this study. Project I was conducted at Hospital Sultanah 
Aminah, Johor Bahru. Project I was carried out in Medical Record Office 
(retrospective) and neonatal intensive care unit (NICU) and neonatal wards 
(prospective). Patients' medication charts, ward notes and laboratory data 
were reviewed daily and progress of the selected patients in the ward were 
documented. Logistic regression was used to analyse potential risk factors 
associated with use of > 5 drugs and DRPs occurrence. As Adverse Drug 
Reaction (ADR) is a subset of DRPs, Project II was carried out at National 
Pharmaceutical Regulatory Agency (NPRA) using the data from the national 
pharmacovigilance database, QUEST2 system to examine the characteristics 
and prevalence of ADRs in neonates in contrast to other paediatric population. 
The systematic review revealed that neonates are exposed to a high number 
of drugs, with antiinfectives for systemic use being the most predominantly 
prescribed. Various methods have been used to quantify drug consumption 
in neonates but no study from Malaysia was identified. In project I, a 
total of 302 neonates were included in the study. The majority of neonates 
admitted to NICU and neonatal wards were preterm (63.2%, n=191) and 
LBW infants (64.6%, n=195). On average, the neonates were admitted 
for 28.4 days and there were 2715 drugs documented. Antiinfectives 
for systemic use (n=1235, 45.5%) were the most commonly prescribed 
drugs, with benzylpenicillin (n=293) and gentamicin (n=275) being the 
most predominant. Number of diagnoses or problems was found to be 
a significant predictors for neonates to be prescribed with > 5 drugs. In 
total, 768 DRPs were identified for 265 patients, whom had at least one 
DRP. The overall incidence of DRPs was 87.7% and treatment safety 
which relates to adverse drug events had the highest frequency amongst 
the reported problems, 67.1% (n=515). A retrospective analysis of ADRs 
reports received by the national pharmacovigilance centre in project II 
found that antibacterial for systemic use were commonly associated with 
ADRs in Malaysian children with majority of them manifested through 
skin reactions. ADRs reported for neonates was lower than other children 
age categories. Inappropriate dose, 60.0% (n=572) and drug selection 
21.4% (n=204) were the common causes for DRPs identified. The number 
of drugs prescribed was the only potential risk factor that was found to 
be significant for the occurrence of DRPs. Neonates are exposed to high 
number of drugs and are at risk of developing DRPs. Pharmacists should 
set priority for the preterm and LBW neonates who have multiple diagnoses 
and prescribed with multiple drugs in order to minimize the risks of DRPs 
and subsequently improve efficiency of clinical pharmacy services. 
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